JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies
Gina A. Montealegre Sanchez(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Jonathan Janes(Eli Lilly (United States)), Edward W. Cowen(National Institutes of Health), Volker Nickeleit(University of North Carolina at Chapel Hill), Deborah L. Stone(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Susanne Schalm(LMU Klinikum), James C. Reynolds(National Institutes of Health Clinical Center), Rebecca J. Brown(National Institutes of Health), Ariane Soldatos(National Institute of Neurological Disorders and Stroke), Suzanne Ramsey(Dalhousie University), Dirk Foell(Klinik für Schlafmedizin), Robert A. Colbert(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Jason Dare(University of Arkansas for Medical Sciences), Yackov Berkun(Hadassah Medical Center), Nargues Weir(National Heart Lung and Blood Institute), Katherine R. Calvo(National Institutes of Health Clinical Center), Harsharan K. Singh(University of North Carolina at Chapel Hill), Colleen Hadigan(National Institutes of Health), Kristina I. Rother(National Institutes of Health), Adriana A. de Jesus(National Institute of Allergy and Infectious Diseases), Scott M. Paul(National Institutes of Health Clinical Center), Steven M. Holland(National Institute of Allergy and Infectious Diseases), Dawn Chapelle(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Helmut Wittkowski(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Parag Kumar(National Institutes of Health Clinical Center), Alessandra Brofferio(National Heart Lung and Blood Institute), Ling Gao(Qingdao University), Laura Failla(National Institute of Allergy and Infectious Diseases), Les Folio(National Institutes of Health Clinical Center), Ahmad S. Alawad(Johns Hopkins University), Samantha Dill(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Kristina M. Brooks(National Institutes of Health Clinical Center), Theo Heller(National Institutes of Health), Andrew Lipton(Walter Reed National Military Medical Center), Stephen R. Brooks(National Biodiversity Institute), Massimo Gadina(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Hanna Kim(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Joseph R. Fontana(National Heart Lung and Blood Institute), Meryl Waldman(National Institutes of Health), Thomas Klausmeier(Riley Hospital for Children), Angélique Biancotto(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Apurva Prakash(Eli Lilly (United States)), Sara Murías(Hospital Universitario Central de Asturias), Michelle O’Brien(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Philip J. Hashkes(Shaare Zedek Medical Center), Bahar Kost(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Maria Silk(Eli Lilly (United States)), John J. DiGiovanna(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Adam Reinhardt(Nebraska Medical Center), Diane E. Brown(Museum of Boulder)
Cited by 519
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions
|American Journal of Transplantation|2008|1.9k
Increased Acute Myocardial Infarction Rates and Cardiovascular Risk Factors among Patients with Human Immunodeficiency Virus Disease
|The Journal of Clinical Endocrinology & Metabolism|2007|1.6k
Activated STING in a Vascular and Pulmonary Syndrome
|New England Journal of Medicine|2014|1.4k